Graham Capital Management »

Lyell Immunopharma shares owned by Graham Capital Management

Quarter-by-quarter ownership of Lyell Immunopharma (LYEL) shares owned by Graham Capital Management from 13F filings

Historical chart of Graham Capital Management investment in Lyell Immunopharma

Tip: Access up to 7 years of quarterly data

All positions including Lyell Immunopharma held by Graham Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lyell Immunopharma by Graham Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $49k 22k 2.23
2023-12-31 $50k 26k 1.94

More positions owned by Graham Capital Management

Microstrategy Cl A New (MSTR)
Ishares Tr Russell 2000 Etf (IWM)
Microstrategy Note 0.750%12/1 (Principal)
Permian Resources Corp Note 3.250% 4/0 (Principal)
Zillow Group Note 0.750% 9/0 (Principal)
Microstrategy Note 2/1 (Principal)
Peabody Engr Corp Note 3.250% 3/0 (Principal)
Tilray Brands Note 5.200% 6/1 (Principal)
Ishares Bitcoin Tr SHS
Bridgebio Pharma Note 2.500% 3/1 (Principal)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Transocean Deb 4.000%12/1 (Principal)
Coinbase Global Note 0.500% 6/0 (Principal)
Dollar General (DG)
Green Plains Note 2.250% 3/1 (Principal)

View all positions for Graham Capital Management

Top funds holding Lyell Immunopharma

BlackRock
Vanguard Group
Foresite Capital Management IV
WuXi AppTec
T. Rowe Price Associates
Alphabet
Geode Capital Management
Opaleye Management
Sc China Holding
FMR
Millennium Management
MIC Capital Management UK
Massachusetts Financial Services
Northern Trust
Charles Schwab Investment Management

View all funds holding Lyell Immunopharma